Mazor Robotics (MZOR) Upgraded to “Strong-Buy” at BidaskClub

Share on StockTwits

BidaskClub upgraded shares of Mazor Robotics (NASDAQ:MZOR) from a buy rating to a strong-buy rating in a research report sent to investors on Friday morning.

Other equities analysts have also recently issued reports about the stock. Zacks Investment Research cut shares of Mazor Robotics from a hold rating to a sell rating in a research report on Thursday, August 9th. ValuEngine cut shares of Mazor Robotics from a buy rating to a hold rating in a research report on Tuesday, August 28th. Finally, Needham & Company LLC upgraded shares of Mazor Robotics from an underperform rating to a hold rating in a research report on Friday, September 21st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, two have given a buy rating and two have issued a strong buy rating to the company. The stock currently has a consensus rating of Buy and a consensus price target of $61.08.

Shares of NASDAQ:MZOR traded up $0.15 during midday trading on Friday, hitting $58.01. The stock had a trading volume of 1,355,874 shares, compared to its average volume of 536,200. The stock has a market capitalization of $1.54 billion, a PE ratio of -116.02 and a beta of 1.43. Mazor Robotics has a fifty-two week low of $41.60 and a fifty-two week high of $76.56.

Mazor Robotics (NASDAQ:MZOR) last issued its earnings results on Thursday, August 2nd. The medical instruments supplier reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.13). The firm had revenue of $13.20 million during the quarter, compared to analyst estimates of $17.02 million. Mazor Robotics had a negative net margin of 12.80% and a negative return on equity of 7.17%. Mazor Robotics’s quarterly revenue was down 14.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.05) earnings per share. On average, sell-side analysts forecast that Mazor Robotics will post -0.12 EPS for the current fiscal year.

A number of hedge funds have recently added to or reduced their stakes in the stock. Advisors Asset Management Inc. bought a new stake in Mazor Robotics during the 2nd quarter worth approximately $451,000. Global X Management Co LLC grew its holdings in Mazor Robotics by 19.7% during the 2nd quarter. Global X Management Co LLC now owns 506,196 shares of the medical instruments supplier’s stock worth $28,099,000 after acquiring an additional 83,387 shares during the last quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management grew its holdings in Mazor Robotics by 21.9% during the 2nd quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 278,119 shares of the medical instruments supplier’s stock worth $15,438,000 after acquiring an additional 50,000 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. grew its holdings in Mazor Robotics by 6.3% during the 2nd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 224,337 shares of the medical instruments supplier’s stock worth $12,453,000 after acquiring an additional 13,200 shares during the last quarter. Finally, Dorsey Wright & Associates grew its holdings in Mazor Robotics by 16.9% during the 2nd quarter. Dorsey Wright & Associates now owns 192,549 shares of the medical instruments supplier’s stock worth $10,648,000 after acquiring an additional 27,809 shares during the last quarter. Institutional investors and hedge funds own 23.98% of the company’s stock.

About Mazor Robotics

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures.

Recommended Story: Stop Order

Analyst Recommendations for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.